Boston Scientific to Participate in 11th Annual SVB Leerink Global Healthcare Conference

 

MARLBOROUGH, Mass., Feb. 14, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in SVB Leerink's 11th Annual Global Healthcare Conference on Thursday, February 17, 2022.

Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at approximately 9:20 a.m. EST. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.

The replay of the webcast will be accessible at investors.bostonscientific.com. beginning approximately one hour following the completion of the event.

About Boston Scientific

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS                         

 

Media:                                   

Investors:

Kate Haranis                          

Lauren Tengler

508-683-6585 (office)            

508-683-4479 (office)

Media Relations                      

Investor Relations

Boston Scientific Corporation  

Boston Scientific Corporation

Kate.Haranis@bsci.com           

BSXInvestorRelations@bsci.com

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-11th-annual-svb-leerink-global-healthcare-conference-301481578.html

SOURCE Boston Scientific Corporation

 
 
Company Codes: NYSE:BSX
 

Back to news